The project, which has been running for more than two years, employs some of the same methods
used by drug companies.
These same tools can potentially be
used by drug companies to identify new targets for treating many diseases and conditions.
Not exact matches
While the tax bill has been promoted
by Republicans as a job creator, the reality is that
drug companies are more likely to return the money to shareholders, or
use it to make acquisitions.
The key is to avoid a
company that has only a few
drugs in the pipeline that one day may or may not be approved for
use by the FDA.
Shkreli originally became infamous for his other former
company Turing Pharma's 5,000 % price hike for a
drug used by cancer and AIDS patients.
But the initiative comes with another huge financial prize for firms that successfully win FDA approval for these niche therapies: a priority review voucher that can be
used to slash the regulatory period for a different experimental specialty treatment being developed
by a
drug maker or, more often, sold for potentially hundreds of millions of dollars to another pharma
company.
These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products
using our proprietary technologies, which may lead to competition from generic
drug manufacturers; data from clinical trials may be interpreted
by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the
company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the
company's products or an increase in the
company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the
company's products; the
company's products may prove difficult to manufacture, be precluded from commercialization
by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the
company's most recent Annual Report on Form 10 - K and in subsequent filings made
by the
company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.
Martin Shkreli, unaffectionately known as the «pharma bro» — and infamous for his decision to hike the list price of Daraprim, a
drug used by HIV / AIDS and cancer patients to combat infections,
by more than 5,000 % in 2015 under his former
company Turing Pharmaceuticals — was convicted on three criminal securities fraud and conspiracy charges
by a Brooklyn jury on Friday.
The
company is selling a thing (the kit)
by saying it can provide «health reports on 254 diseases and conditions,» including categories such as «carrier status,» «health risks,» and «
drug response,» and specifically as a «first step in prevention» that enables users to «take steps toward mitigating serious diseases» such as diabetes, coronary heart disease, and breast cancer...» Most of the
uses «listed on your website, a list that has grown over time,» the FDA writes, «are medical device
uses [for the] Personal Genome Service.»
«We have an agreement with them where we own the
drug, but anything that's funded
by the U.S. government, it reserves the right to
use that under certain circumstances,» says Mark Murray, president and CEO of the Burnaby, B.C.,
company.
The article described how an internal investigation conducted
by a
company executive, Dinesh Thakur, who went on to become a whistleblower, reported appalling deceit: Ranbaxy scientists substituted cheaper, lower - quality ingredients in place of better ingredients, manipulated test parameters, and even bought brand - name
drugs and
used them in place of their own generics to win FDA approval.
The
company focuses on cancer
drug research and has a platform for so - called «real - world» data, which can be
used to assess the economic value of medicines and is sought after
by drug makers looking to justify their prices to health insurers.
The FDA's action cuts off a vital supply line for the
company, given that the plant reportedly makes about 70 % of the ingredients that Ranbaxy
uses to make its U.S.
drugs, including the generic version of Lipitor taken
by millions of Americans.
First, patents are often taken out to
use as legal weapons
by huge
companies to fight off their competitors even if they do not plan on completing trials for the
drug.
Drug companies used to stay one step ahead
by continually introducing new medications, but bacteria have been mutating rapidly in response, making the
drugs less effective.
«But we have to be honest and say that, based on all the evidence, including data presented
by the
drug companies themselves, our experts have concluded that these
drugs do not make enough of a difference for us to recommend their
use for treating all stages of Alzheimer's disease.
Biohacker Andrew Hessel «s open - source
drug company aims to make bespoke cancer - fighting viruses
using DNA printers — paid for
by a Netflix - style subscription
Last year, the Food and
Drug Administration approved the first medical machine learning algorithm for commercial
use by the San Francisco
company Arterys.
Wilmut's work is supported
by a biotechnology
company, PPL Therapeutics in Edinburgh, which plans to
use the patented cloning technique to produce animals that will secrete valuable
drugs in their milk.
In September, the FDA also required that,
by November 2007,
drug companies stop making unapproved prescription
drugs containing the narcotic cough suppressant hydrocodone for
use by children younger than 6.
Blood transfusions
used for this purpose do not require approval
by the US Food and
Drug Administration, and some American
companies are already charging hefty fees for transfusions of blood from young people.
AVI BioPharma's chief executive, Chris Garabedian, says that the
company's technology is safer than that tested
by other
drug firms, and thus can be
used in higher doses that are more likely to be effective than other antisense
drugs that have failed in the past.
Eye injections of the
drug Avastin,
used to treat retinal diseases, bring no greater risk of endophthalmitis, a potentially blinding eye infection, than injections with the much more expensive
drug Lucentis made
by the same
company, according to new research from the Perelman School of Medicine at the University of Pennsylvania.
When
drug companies realized the potential to expand stimulant sales to adults, they devised a new market, to which Schwarz attributes the rising recreational
use of ADHD
drugs by students, professors, shift workers, doctors and others with demanding schedules.
Another method
used broadly
by RNAi
companies is «GalNAc» — a sugar derivative that's attached to RNAi
drugs to help it safely work in the liver.
By revealing skin sensitisation or an adverse reaction that may not be identified by use of an animal or computer model, the assay can provide vital information which will allow a drug company to make informed decisions earlier saving significant development cost
By revealing skin sensitisation or an adverse reaction that may not be identified
by use of an animal or computer model, the assay can provide vital information which will allow a drug company to make informed decisions earlier saving significant development cost
by use of an animal or computer model, the assay can provide vital information which will allow a
drug company to make informed decisions earlier saving significant development costs.
The microbes need to increase output of thebaine
by a factor of 100,000 for
drug companies to be interested in
using them to make medicines.
Barry Schonwetter and colleagues at the Magainin Research Institute, a private laboratory run
by the
drugs company Magainin Pharmaceuticals in Plymouth Meeting, Pennsylvania, took cells from the surface of cows» tongues and
used organic solvents to extract several chemicals.
A new project
by the National Institutes of Health aims to persuade
drug companies to open up their troves of abandoned
drugs to academics, who would look for new
uses.
Companies that uncover such mutations can profit by selling that knowledge to pharmaceutical companies, which can use it to develop diagnostic tests a
Companies that uncover such mutations can profit
by selling that knowledge to pharmaceutical
companies, which can use it to develop diagnostic tests a
companies, which can
use it to develop diagnostic tests and
drugs.
The chemical reactions she has developed are widely
used throughout the pharmaceutical industry to create new
drug candidates, are being studied
by chemical
companies interested in accessing important chemicals
used in farming, and are being utilized to prepare a type of chemical (tracer) that allows doctors to view the heart's sympathetic nervous system through positron emission tomography (PET) scans.
Dr. Allison: One of the barriers that frustrates many of the people in the field is that the different
drugs which could be
used in combination are sometimes held
by different
companies.
This method is
used by 80 % of major pharmaceutical
companies and has contributed to the development of several approved
drugs.
Consequently, the safest investment in the ESC field may be «something where you're an enabler of the technology»
by providing the raw tools and ingredients for ESC research, says Steve Brozak, an analyst with WBB Securities in San Diego, Calif. «The time frame [for ESCs] is now for
drug discovery, soon for personalized medicine, and decades for therapeutic
use,» adds Bob Palay, chairman and CEO of Cellular Dynamics International (CDI), a biotech
company working with ESCs in Madison, Wisc..
The symposium we've convened addresses the ways Organs - on - Chips technology is being
used for
drug development
by pharmaceutical
companies and for precision medicine
by clinicians.
This approach is being
used by WAVE Life Sciences, a
company working on developing allele - specific huntingtin lowering
drugs for HD.
SAN DIEGO, March 28, 2017 (GLOBE NEWSWIRE)-- Invivoscribe ® Technologies Inc., a global
company with decades of experience providing internationally standardized clonality and biomarker testing solutions for the fields of oncology, personalized molecular diagnostics ®, and personalized molecular medicine ®, reports that its next - generation sequencing (NGS) LymphoTrack ® Assay kits are being
used by its LabPMM ® clinical laboratories, pharmaceutical partners, and cancer centers to identify and monitor chimeric antigen receptor T - cells (CAR - T) and engineered T - cell receptors in peripheral blood of subjects in support of immuno - therapeutic
drug development and treatment regimen development for both hematologic and solid tumors.
I visited a renowned trichologist and she suggested medicated shampoos containing ketoconazole, an anti-fungal
drug used extensively
by cosmetic
companies.
Dr Santoro represents mainstream medicine and synthetic hormones sold
by the major
drug companies, and as such
uses coded language which requires translation.
The Growth Factors Must Exist in the Proper ProportionsFor years
drug - engineering (pharmaceutical)
companies have synthesized the anti-aging components of colostrum, and these synthetic growth factors have been
used by wealthy patrons in expensive anti-aging clinics.
Nina and I are friends as well, even though I say her name wrong, who has also written some books about fat, but there's this national conversation where you have the old school low - fats, mostly paid for
by big grain sort of research out there, and you're refuting some of that
using very strong academics, randomized controlled trials, and the things that everyone wants, but no one has paid for except for maybe big
drug companies and things like that.
As a perfectly absurd example of how doctors have been wrongly influenced
by the
drug companies... about 8 years ago, I was a perfectly healthy 28 year old, in great shape, exercising daily, eating a balanced healthy diet full of antioxidants and quality nutrition, no smoking, and with no real risk factors for heart disease, and just because my cholesterol level has been consistently measured over 200 for my entire life, my doctor recommended I consider
using a cholesterol lowering statin
drug.
I am simply asking you to question whether your medication is absolutely necessary or is simply being pushed on you
by a powerful
company for profit or a doctor who is doing the only thing he was taught —
using drugs to treat every ailment.
But the Food and
Drug Administration has long affirmed that the sweetener is safe in amounts commonly
used by beverage
companies.
Winchester (PG - 13 for violence, sexuality,
drug use, mature themes and disturbing images) Revenge flick revolving around a Winchester Gun heiress (Helen Mirren) whose house is haunted
by the ghosts of people killed
by her
company's repeating rifle.
Adequan is a
drug manufactured
by Lupitold, a very small
company, and it is expensive and not frequently
used by veterinarians.
Why, it's the Interior Department's Minerals Management Service, which was just revealed
by the department's inspector general to have engaged in
drug use, gifts, and illicit sex with oil
company executives.
The
company's technology detects
drug use by analysing the sweat on the tip of a finger that forms a fingerprint, and its non-invasive approach...
This section establishes programs
by which trucking
companies can work to prevent accidents
by using drug / alcohol testing.
The
company's technology detects
drug use by analysing the sweat on the tip of a finger that forms a fingerprint, and its non-invasive approach provides a rapid and convenient way for Coroners to screen the deceased for recent
drug use.